Drugs / Tritanrix HepB Hib
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01231503 Background | Jan 2011 → Apr 2014 | malaria | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tritanrix HepB Hib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01231503 ↗ |